- ►ascopubs.org [PDF] A Buzdar, W Jonat, A Howell, SE Jones, C … - Journal of Clinical Oncology, 1996 - jco.ascopubs.org Purpose: To compare the efficacy and tolerability of an- astrozole (1 and 10 mg
once daily), a selective, oral, nonste- roidal aromatase inhibitor, and
megestrol acetate (40 mg four times daily), in postmenopausal women who ... Cited by 285 - Related articles - BL Direct - All 11 versions
- ►annals.org M Schambelan, K Mulligan, C Grunfeld, ES … - Annals of internal medicine, 1996 - Am Coll Physicians Background: Body wasting, particularly loss of body cell mass, is an
increasingly prevalent acquired immunodeficiency syndrome (AIDS)-defining
condition and is an independent risk factor for death in patients infected ... Cited by 277 - Related articles - BL Direct - All 7 versions
- ►annals.org S Grinspoon, C Corcoran, H Askari, D … - Annals of internal medicine, 1998 - Am Coll Physicians Background: Development of successful anabolic strategies to reverse the loss of
lean body mass is of critical importance to increase survival in men with the
AIDS wasting syndrome. Hypogonadism, an acquired endocrine deficiency state ... Cited by 191 - Related articles - BL Direct - All 5 versions
- ►anabolicfitness.net [PDF] S Bhasin, TW Storer, M Javanbakht, N Berman, … - Jama, 2000 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Previous studies ... Cited by 181 - Related articles - BL Direct - All 13 versions
W Jonat, A Howell, C Blomqvist, W Eiermann, … - European Journal of Cancer, 1996 - Elsevier The aim of this study was to compare the efficacy and tolerability of the new
aromatase inhibitor 'ARIMIDEX' (anastrozole) with megestrol acetate in the
treatment of advanced breast cancer in postmenopausal women. Anastrozole is ... Cited by 165 - Related articles - BL Direct - All 9 versions
- ►ascopubs.org CL Loprinzi, JW Kugler, JA Sloan, JA … - Journal of Clinical Oncology, 1999 - jco.ascopubs.org PURPOSE: Previous double-blind, placebo-controlled, randomized clinical trials
have demonstrated that both corticosteroids and progestational agents do
partially alleviate cancer anorexia/cachexia. Pilot information suggested ... Cited by 157 - Related articles - BL Direct - All 7 versions
- ►cnfindpark.cn SS Yeh, MW Schuster - American Journal of Clinical Nutrition, 1999 - ajcn.cnfindpark.cn Weight loss in elderly patients is a common clinical problem. Wasting and
cachexia are associated with severe physiologic, psychologic, and immunologic
consequences, regardless of the underlying causes. Cachexia has been ... Cited by 155 - Related articles - BL Direct - All 6 versions
- ►berkeley.edu [PDF] A Strawford, T Barbieri, M Van Loan, E Parks, … - Jama, 1999 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Repletion of ... Cited by 148 - Related articles - All 8 versions
AU Buzdar, SE Jones, CL Vogel, J Wolter, P … - CA A Cancer Journal for Clinicians - interscience.wiley.com Additional members of the Arimidex Study Group who participated in this trial
were Harvey B. Sher, University Professional Center, Jacksonville, FL; David B.
Myers, BIOP, Billings, MT; Carol J. Fabian, University of Kansas Medical ... Cited by 144 - Related articles - BL Direct - All 4 versions
